Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA changes label requirements for abortion-inducing drug, potentially expanding its usage
FDA changes label requirements for abortion-inducing drug, potentially expanding its usage
FDA changes label requirements for abortion-inducing drug, potentially expanding its usage
Submitted by
admin
on March 30, 2016 - 9:16pm
Source:
BioPharma Dive
News Tags:
FDA
labeling
Mifeprex
Headline:
FDA changes label requirements for abortion-inducing drug, potentially expanding its usage
Do Not Allow Advertisers to Use My Personal information
